The Value of Anti-Calretinin Antibody in the Differential Diagnosis of Normal and Reactive Mesothelia versus Metastatic Tumors in Effusion Cytology
- 31 December 1998
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 194 (11) , 759-764
- https://doi.org/10.1016/s0344-0338(98)80065-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Special stains, the old and the new: The impact of immunocytochemistry in effusion cytologyDiagnostic Cytopathology, 1998
- CalretininActa Cytologica, 1997
- Change of calretinin expression in the human colon adenocarcinoma cell line HT29 after differentiationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- Calretinin: A Novel Immunocytochemical Marker for MesotheliomaThe American Journal of Surgical Pathology, 1996
- Ber-EP4 for Differentiating Adenocarcinoma from Reactive and Neoplastic Mesothelial Cells in Serous EffusionsActa Cytologica, 1996
- Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinomaHuman Pathology, 1993
- Expression of the calcium binding protein calretinin in WiDr cells and its correlation to their cell cycleExperimental Cell Research, 1992
- Cytologic diagnosis of malignant mesothelioma in serous effusions using an antimesothelial-cell antibodyDiagnostic Cytopathology, 1992
- Immunoreactivity for BER-EP4 in Adenocarcinomas, Adenomatoid Tumors, and Malignant MesotheliomasThe American Journal of Surgical Pathology, 1992
- Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesotheliomaThe Journal of Pathology, 1991